Get Free Shipping on orders over $79
Interferon : The Dawn of Recombinant Protein Drugs - J. Lindenmann

Interferon

The Dawn of Recombinant Protein Drugs

By: J. Lindenmann (Editor), W.-D. Schleuning (Editor)

Paperback | 3 October 2013

At a Glance

Paperback


$169.00

or 4 interest-free payments of $42.25 with

 or 

Ships in 5 to 7 business days

Forty years of Interferon I wish to dedicate this short introduction to the memory of Alick Isaacs (1921-1967), and to that of Sir Christopher Andrewes (1896-1988). Let us go back more than 40 years. In 1956 Isaacs was in charge of the Wodd Influenza Centre. Andrewes was head of the division of bac­ teriology and virology, and deputy director of the National Institute for Medical Research in London. When researchers are faced with a seemingly new phenomenon, ex­ planations are easy to come by. These explanations fall into two broad categories: the phenomenon in question is either due to something or to the lack of something. I apologize for the primitive way in which I ex­ press this, but I am going to give three examples, scattered over 100 years, of what I mean. First example: in 1880 the great French microbiologist Louis Pas­ teur was involved in work on chicken cholera. He was struck by the following observation: if a suitable chicken broth was inoculated with the bacterium, the organism grew profusely and the liquid became tur­ bid. If he now freed the fluid, by sedimentation or filtration, from the bulk of the organisms and re-inoculated it with the same bacterium, no growth occurred.

More in Biotechnology

Biotechnology Fundamentals - Jaxon Garrison
Introduction to Plant Biotechnology - Nathan Mitchell
Bad Blood : Secrets and Lies in a Silicon Valley Startup - John Carreyrou
The Gene : An Intimate History - Siddhartha Mukherjee

RRP $29.99

$24.99

17%
OFF
Environmental Microbiology : 3rd Edition - Ian Pepper

RRP $170.95

$128.99

25%
OFF
Electric Life : The Hidden Radiance of Everything - Sander Funneman

RRP $55.00

$42.75

22%
OFF